ScienceDaily, December 23, 2015 In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia. In a study published Dec. 24 in the New England Journal of Medicine, the research team compared two of...
New Scientist, 16 November 2015
It could be just what HIV researchers the world over have been waiting for – a non-toxic drug that will drive the virus from its hiding places around the body. What is it? The well-known anti-alcohol drug, Antabuse.
Read more here
AIDSMEDS, August 17, 2015
People with hepatitis B virus (HBV) can safely take Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP), as it does not lead to liver inflammation “flares” or other health problems when it is used or discontinued.
Read more here
nam, 27 July 2015
An open-label demonstration project of Truvada pre-exposure prophylaxis (PrEP) in the United States has found generally high retention and adherence rates, with the highest adherence among those at the highest risk of HIV.
Read more here
The Independent, Thursday 16 July 2015
The topic of sex is constantly talked about in the media, yet there is a taboo surrounding the issues that many people with disabilities face when they want to have sex, or even talk about sex, both from the general public and the medical profession.
Read more here
Access Sexual Respect Toolkit here
Reuters, Mon Mar 23, 2015
When teens take pills for depression and anxiety, doctors need to make sure they understand that sexual side effects are common with the drugs, a new paper advises.
Read more here